These schemes of the Department of Pharmaceuticals were approved by the Union Cabinet in March this year.
Read More
The Drug Controller General of India granted Cipla accelerated approval to make and sell favipiravir in an effort to meet the "urgent and unmet" need for COVID-19 treatment options in the country
Read More
With the trials of COVID-19 vaccine being developed by AstraZeneca and Oxford University showing encouraging results, the Serum Institute of India (SII) has said it will apply for license from the Indian regulator to start clinical trials of the shot in a week's time.
Read More
Glenmark also denied making any claims that "favipiravir alone" is effective in treatment of mild-to-moderate COVID-19 patients.
Read More
Telemedicine can help us overcome the barriers to accessing healthcare services – distance between provider and patient, access to transportation, fragmented care caused due to gaps in appointments, and lack of healthcare access.
Read More
The talks follow a deal reached in June by four EU member states with AstraZeneca for the upfront purchase of 400 million doses of its potential COVID-19 vaccine, in principle available to all 27 EU nations.
Read More
"We urge the administration to fully leverage all authorities including the Defense Production Act and other tools to ensure adequate supplies of remdesivir," the IDSA said.
Read More
India's approval for Zydus comes days after privately held Bharat Biotech got a similar green light for human studies for its vaccine candidate.
Read More
